Literature DB >> 29313470

Serological Markers of Recent Campylobacter jejuni Infection in Patients with Guillain-Barré Syndrome in the State of Piauí, Brazil, 2014-2016.

Cintya O Souza1, Marcelo A C S Vieira2,3,4, Francisca M A Batista5, Kelsen D Eulálio3,4, Jéssica M M Neves6, Laís C Sá7, Leni C R Monteiro1, Walfrido S Almeida-Neto4, Raimunda S S Azevedo8, Dorcas L Costa9, Ana C R Cruz8.   

Abstract

In countries where poliomyelitis has been eradicated, Guillain-Barré syndrome (GBS) is the leading cause of acute flaccid paralysis. The range of infections that precede GBS in Brazil is unknown. Campylobacter jejuni infection is the most frequent trigger of GBS worldwide. Given the lack of systematic surveillance of diarrheal diseases, particularly in adults, the incidence of enteritis caused by C. jejuni in developing countries is unknown. From 2014 to 2016, pretreatment serum samples from 63 GBS patients were tested by immunoglobulin M (IgM) enzyme-linked immunosorbent assay for C. jejuni. Campylobacter jejuni IgM antibodies were detected in 17% (11/63) of the samples. There was no association between serological positivity (IgM) for C. jejuni and the occurrence of diarrhea among the investigated cases (P = 0.36). Hygiene measures, basic sanitation, and precautions during handling and preparation of food of animal origin may help prevent acute flaccid paralysis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29313470      PMCID: PMC5929210          DOI: 10.4269/ajtmh.17-0666

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Guillain-Barré syndrome: an Italian multicentre case-control study. Guillain-Barré Syndrome Study Group.

Authors: 
Journal:  Neurol Sci       Date:  2000-08       Impact factor: 3.307

Review 2.  The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review.

Authors:  Anita McGrogan; Gemma C Madle; Helen E Seaman; Corinne S de Vries
Journal:  Neuroepidemiology       Date:  2008-12-17       Impact factor: 3.282

3.  Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.

Authors:  Ruprecht Schmidt-Ott; Holger Schmidt; Sylvia Feldmann; Felicitas Brass; Bernd Krone; Uwe Gross
Journal:  Clin Vaccine Immunol       Date:  2006-07

4.  Campylobacter jejuni and Campylobacter coli in children from communities in Northeastern Brazil: molecular detection and relation to nutritional status.

Authors:  Josiane da Silva Quetz; Ila Fernanda Nunes Lima; Alexandre Havt; Eunice Bobo de Carvalho; Noélia Leal Lima; Alberto Melo Soares; Rosa Maria Salani Mota; Richard Littleton Guerrant; Aldo Angelo Moreira Lima
Journal:  Diagn Microbiol Infect Dis       Date:  2010-07       Impact factor: 2.803

5.  Occurrence of Campylobacter jejuni in diarrhoeic and non-diarrhoeic children in São Paulo, Brazil.

Authors:  H Fernández; M R Toledo; U Fagundes Neto; L R Trabulsi
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1985 Mar-Apr       Impact factor: 1.846

6.  Early recognition of poor prognosis in Guillain-Barre syndrome.

Authors:  C Walgaard; H F Lingsma; L Ruts; P A van Doorn; E W Steyerberg; B C Jacobs
Journal:  Neurology       Date:  2011-03-15       Impact factor: 9.910

Review 7.  Human campylobacteriosis in developing countries.

Authors:  Akitoye O Coker; Raphael D Isokpehi; Bolaji N Thomas; Kehinde O Amisu; C Larry Obi
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

8.  Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.

Authors:  F J Vriesendorp; B Mishu; M J Blaser; C L Koski
Journal:  Ann Neurol       Date:  1993-08       Impact factor: 10.422

Review 9.  Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.

Authors:  Pieter A van Doorn; Liselotte Ruts; Bart C Jacobs
Journal:  Lancet Neurol       Date:  2008-10       Impact factor: 44.182

Review 10.  Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barré Syndrome: Systematic Review.

Authors:  Fabienne Krauer; Maurane Riesen; Ludovic Reveiz; Olufemi T Oladapo; Ruth Martínez-Vega; Teegwendé V Porgo; Anina Haefliger; Nathalie J Broutet; Nicola Low
Journal:  PLoS Med       Date:  2017-01-03       Impact factor: 11.069

View more
  4 in total

1.  Genotypical Relationship Between Human and Poultry Strains of Campylobacter jejuni.

Authors:  Roberta Torres de Melo; Carolyne Ferreira Dumont; Raquelline Figueiredo Braz; Guilherme Paz Monteiro; Micaela Guidotti Takeuchi; Eduarda Cristina Alves Lourenzatto; Jandra Pacheco Dos Santos; Daise Aparecida Rossi
Journal:  Curr Microbiol       Date:  2021-06-05       Impact factor: 2.188

Review 2.  Persistence and clinical relevance of Zika virus in the male genital tract.

Authors:  Fábio A Kurscheidt; Cristiane S S Mesquita; Gabrielle M Z F Damke; Edilson Damke; Analine R B de A Carvalho; Tamy T Suehiro; Jorge J V Teixeira; Vânia R S da Silva; Raquel P Souza; Marcia E L Consolaro
Journal:  Nat Rev Urol       Date:  2019-04       Impact factor: 14.432

3.  Incidence of Guillain-Barré Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: A systematic review and meta-analysis.

Authors:  Ariadna Capasso; Danielle C Ompad; Dorice L Vieira; Annelies Wilder-Smith; Yesim Tozan
Journal:  PLoS Negl Trop Dis       Date:  2019-08-26

4.  Antecedent infections in Guillain-Barré syndrome in endemic areas of arbovirus transmission: A multinational case-control study.

Authors:  Sonja E Leonhard; Cheng Yin Tan; Annemiek A van der Eijk; Ricardo R Reisin; Suzanne C Franken; Ruth Huizinga; Samuel Arends; Manou R Batstra; Selma M Bezerra Jeronimo; Judith Drenthen; Laura de Koning; Luciana Leon Cejas; Cintia Marchesoni; Wilson Marques; Nortina Shahrizaila; Dardo F Casas; Andrea Sotelo; Belen Tillard; Mario-Emilio Dourado; Bart C Jacobs
Journal:  J Peripher Nerv Syst       Date:  2021-09-30       Impact factor: 5.188

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.